PMID- 10064899 OWN - NLM STAT- MEDLINE DCOM- 19990413 LR - 20190610 IS - 0006-3002 (Print) IS - 0006-3002 (Linking) VI - 1437 IP - 2 DP - 1999 Feb 25 TI - A specific human lysophospholipase: cDNA cloning, tissue distribution and kinetic characterization. PG - 157-69 AB - Lysophospholipases are critical enzymes that act on biological membranes to regulate the multifunctional lysophospholipids; increased levels of lysophospholipids are associated with a host of diseases. Herein we report the cDNA cloning of a human brain 25 kDa lysophospholipid-specific lysophospholipase (hLysoPLA). The enzyme (at both mRNA and protein levels) is widely distributed in tissues, but with quite different abundances. The hLysoPLA hydrolyzes lysophosphatidylcholine in both monomeric and micellar forms, and exhibits apparent cooperativity and surface dilution kinetics, but not interfacial activation. Detailed kinetic analysis indicates that the hLysoPLA binds first to the micellar surface and then to the substrate presented on the surface. The kinetic parameters associated with this surface dilution kinetic model are reported, and it is concluded that hLysoPLA has a single substrate binding site and a surface recognition site. The apparent cooperativity observed is likely due to the change of substrate presentation. In contrast to many non-specific lipolytic enzymes that exhibit lysophospholipase activity, hLysoPLA hydrolyzes only lysophospholipids and has no other significant enzymatic activity. Of special interest, hLysoPLA does not act on plasmenylcholine. Of the several inhibitors tested, only methyl arachidonyl fluorophosphonate (MAFP) potently and irreversibly inhibits the enzymatic activity. The inhibition by MAFP is consistent with the catalytic mechanism proposed for the enzyme - a serine hydrolase with a catalytic triad composed of Ser-119, Asp-174 and His-208. FAU - Wang, A AU - Wang A AD - Department of Chemistry and Biochemistry, University of California at San Diego, La Jolla, CA 92093-0601, USA. FAU - Yang, H C AU - Yang HC FAU - Friedman, P AU - Friedman P FAU - Johnson, C A AU - Johnson CA FAU - Dennis, E A AU - Dennis EA LA - eng GR - GM 2050/GM/NIGMS NIH HHS/United States GR - GM 51606/GM/NIGMS NIH HHS/United States GR - HD 26171/HD/NICHD NIH HHS/United States PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, P.H.S. PL - Netherlands TA - Biochim Biophys Acta JT - Biochimica et biophysica acta JID - 0217513 RN - 0 (DNA, Complementary) RN - 0 (Membrane Glycoproteins) RN - 0 (RNA, Messenger) RN - 0 (Recombinant Proteins) RN - EC 3.1.1.32 (Phospholipases A) RN - EC 3.1.1.5 (Lysophospholipase) RN - EC 3.1.4.- (Phosphoric Diester Hydrolases) RN - EC 3.1.4.1 (ectonucleotide pyrophosphatase phosphodiesterase 1) RN - EC 3.6.1.- (Pyrophosphatases) SB - IM MH - Amino Acid Sequence MH - Animals MH - Base Sequence MH - Brain/enzymology MH - Cloning, Molecular MH - DNA, Complementary/biosynthesis MH - Escherichia coli/genetics/metabolism MH - Gene Expression MH - Humans MH - Kinetics MH - Lysophospholipase/biosynthesis/chemistry/*genetics MH - Membrane Glycoproteins/pharmacology MH - Molecular Sequence Data MH - Muscle, Skeletal/enzymology MH - Myocardium/enzymology MH - Phospholipases A/analysis MH - *Phosphoric Diester Hydrolases MH - Placenta/enzymology MH - *Pyrophosphatases MH - RNA, Messenger/analysis MH - Rats MH - Recombinant Proteins/chemistry MH - Substrate Specificity EDAT- 1999/03/05 00:00 MHDA- 1999/03/05 00:01 CRDT- 1999/03/05 00:00 PHST- 1999/03/05 00:00 [pubmed] PHST- 1999/03/05 00:01 [medline] PHST- 1999/03/05 00:00 [entrez] AID - S1388-1981(99)00012-8 [pii] AID - 10.1016/s1388-1981(99)00012-8 [doi] PST - ppublish SO - Biochim Biophys Acta. 1999 Feb 25;1437(2):157-69. doi: 10.1016/s1388-1981(99)00012-8.